Transplantation And Cellular Therapy impact factor, indexing, ranking (2022)


Transplantation

Aim and Scope

Transplantation And Cellular Therapy is a research journal that publishes research related to Hematology. This journal is published by Elsevier. The P-ISSN of this journal is 26666375.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Transplantation and Cellular Therapy.

Transplantation And Cellular Therapy Ranking

Impact Factor: N/A
Total Citations: 0
SJR (SCImago Journal Rank): 0
Quartile: Q1

The Impact Factor of Transplantation And Cellular Therapy is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title: Transplantation and Cellular Therapy
Publisher: Elsevier
P-ISSN: 26666375
Open Access: YES
Subject: Hematology
Citescore: 6.9
SNIP: 0
SJR: 0
Quartile: 1

Transplantation and Cellular Therapy Indexing

The Transplantation and Cellular Therapy is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Transplantation And Cellular Therapy Impact Factor 2022

The latest impact factor of Transplantation and Cellular Therapy is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.


Transplantation And Cellular Therapy Quartile

The latest Quartile of Transplantation and Cellular Therapy is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Transplantation And Cellular Therapy?

This journal covers the fields/ categories related to Hematology. If your research field is related to Hematology, then visit the official website of Transplantation and Cellular Therapy and send your manuscript.

Tips for publishing in Transplantation And Cellular Therapy:

  • Selection of research problem.
  • Presenting a solution.
  • Designing the paper.
  • Make your manuscript publication worthy.
  • Write an effective results section.
  • Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Review Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.


Final Summary

  • The impact factor of Transplantation and Cellular Therapy is N/A.
  • It is published by Elsevier.
  • The journal is indexed in UGC CARE, Scopus, SCIE.
  • The (SJR) SCImago Journal Rank is 0.
  • The Transplantation and Cellular Therapy is a reputed research journal.

Sources:

https://www.scopus.com/sourceid/21101038539







Similiar Journals


ANEMIA
ISSN: 2090-1267
Publisher: HINDAWI LTD

ASIAN JOURNAL OF TRANSFUSION SCIENCE
ISSN: 0973-6247
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

BLOOD CANCER DISCOVERY
ISSN: 2643-3230
Publisher: AMER ASSOC CANCER RESEARCH

BLOOD RESEARCH
ISSN: 2287-979X
Publisher: KOREAN SOC HEMATOLOGY

CASE REPORTS IN HEMATOLOGY
ISSN: 2090-6560
Publisher: HINDAWI LTD

DRUGS AND CELL THERAPIES IN HEMATOLOGY
ISSN: 2281-4876
Publisher: PAGEPRESS PUBL

EGYPTIAN JOURNAL OF HAEMATOLOGY
ISSN: 1110-1067
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

HEMASPHERE
ISSN: 2572-9241
Publisher: LIPPINCOTT WILLIAMS & WILKINS

HEMATOLOGIE
ISSN: 1264-7527
Publisher: JOHN LIBBEY EUROTEXT LTD

HEMATOLOGY REPORTS
ISSN: 2038-8322
Publisher: PAGEPRESS PUBL

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.